Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 11, Pages e48801
Publisher
Public Library of Science (PLoS)
Online
2012-11-10
DOI
10.1371/journal.pone.0048801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Excessive Fructose Intake on Health
- (2013) Richard J. Johnson et al. ANNALS OF INTERNAL MEDICINE
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
- (2011) Yu Li et al. Cell Metabolism
- The Emerging Role of Endocrine Disruptors in Pathogenesis of Insulin Resistance: A Concept Implicating Nonalcoholic Fatty Liver Disease
- (2011) S. A. Polyzos et al. CURRENT MOLECULAR MEDICINE
- Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
- (2011) A. I. Schmid et al. DIABETES CARE
- The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
- (2011) Emma Barroso et al. ENDOCRINOLOGY
- Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver
- (2011) Eun-Jeong Jung et al. JOURNAL OF LIPID RESEARCH
- Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake
- (2011) Carlos A. Roncal-Jimenez et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Musso et al. Annual Review of Medicine
- AMPK Activators as Novel Therapeutics for Type 2 Diabetes
- (2010) Li-Fang Yu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
- (2010) Jiangyong Ouyang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease: The Roles of Fetuin-A, Adiponectin, and AMPK
- (2010) J. H. Ix et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Proteomics analysis of cardiac muscle from rats with peroxisomal proliferator-activated receptor α (PPARα) stimulation
- (2010) Masafumi Miyazaki et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study
- (2010) Chengfu Xu et al. PLoS One
- Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study
- (2009) Llorenç Caballería et al. BMC GASTROENTEROLOGY
- Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance
- (2009) Kimber L Stanhope et al. CURRENT OPINION IN LIPIDOLOGY
- Association Between Serum Uric Acid and Development of Type 2 Diabetes
- (2009) S. Kodama et al. DIABETES CARE
- Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver
- (2009) Laura G. Sánchez-Lozada et al. EUROPEAN JOURNAL OF NUTRITION
- ZAC1 Is Up-regulated by Hypertonicity and Decreases Sorbitol Dehydrogenase Expression, Allowing Accumulation of Sorbitol in Kidney Cells
- (2009) Miguel A. Lanaspa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fructose consumption as a risk factor for non-alcoholic fatty liver disease
- (2008) Xiaosen Ouyang et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started